Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...

The United Kingdom's Court of Appeal has issued an important decision on the principles governing the grant of interim licenses in standard ...

The nation’s highest patent court will rehear a case Thursday asking it to restrict the kinds of evidence expert witnesses ...

This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,600 state ...

Last week, oral hearings concluded at the UK Court of Appeal in the ongoing patent licensing dispute between wireless ...

Samsung has signed an agreement with China’s YMTC to use its bonding technology in the production of 400-layer NAND flash ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...

Merck’s push to make Keytruda injectable has triggered a patent dispute with Halozyme. The conflict arises over the use of ...

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

The new formulation of Keytruda, currently under FDA review, is sparking conflict with Halozyme, which makes enzymes that ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...

Shares in pharmaceuticals giant Merck (MRK) weakened today on fears that a patent battle could jeopardize its plans to sell a ...